Intelligent Document Processing Market to be Worth $9.18 Billion by 2031
Meticulous Research®—a leading global...
Pharma Industry Applauds US Supreme Court Ruling on Access to Abortion Pill Mifepristone
Pharma Industry Applauds US Supreme Court Ruling on Access to Abortion Pill MifepristoneThe US Supreme Court has unanimously rejected the petition seeking to restrict the FDA’s approval and relaxed regulation of the medical abortion pill mifepristone, granting nationwide access to the controversial drug.
In the unanimous ruling rendered on Thursday by Justice Kavanaugh on behalf of the court, the judges determined that the anti-abortion doctors, petitioners, and associations did not have the legal right to file the petition, maintaining a status quo on access to mifepristone.
Please login to comment on this Post